Relative Vaccine Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among Veterans Health Administration Patients
- PMID: 29452380
- DOI: 10.1093/infdis/jiy088
Relative Vaccine Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among Veterans Health Administration Patients
Abstract
Background: We examined whether a high-dose inactivated influenza vaccine was more efficacious in preventing hospitalizations than a standard-dose vaccine in the Veterans Health Administration (VHA) senior population.
Methods: This study estimated the relative vaccine effectiveness (rVE) of high dose versus standard dose using a retrospective cohort of VHA patients 65 years of age or older in the 2015-2016 influenza season. To adjust for measured confounders, we matched each high-dose recipient with up to 4 standard-dose recipients vaccinated at the same location within a 2-week period and having 2 or more pre-existing medical comorbidities. We used the previous event rate ratio method (PERR), a type of difference-in-differences analysis, to adjust for unmeasured confounders.
Results: We evaluated 104965 standard-dose and 125776 high-dose recipients; matching decreased the population to 49091 standard-dose and 24682 high-dose recipients. The matched, PERR-adjusted rVE was 25% (95% confidence interval [CI], 2%-43%) against influenza- or pneumonia-associated hospitalization, 7% (95% CI, -2% to 14%) against all-cause hospitalization, 14% (95% CI, -8% to 32%) against influenza- or pneumonia-associated outpatient visit, 5% (95% CI, 2%-8%) against all-cause outpatient visit, and 38% (95% CI, -5% to 65%) against laboratory-confirmed influenza.
Conclusions: In protecting senior VHA patients against influenza- or pneumonia-associated hospitalization, a high-dose influenza vaccine is more effective than a standard-dose vaccine.
Similar articles
-
Analysis of relative effectiveness of high-dose versus standard-dose influenza vaccines using an instrumental variable method.Vaccine. 2019 Mar 7;37(11):1484-1490. doi: 10.1016/j.vaccine.2019.01.063. Epub 2019 Feb 8. Vaccine. 2019. PMID: 30745146
-
Comparative effectiveness of high-dose versus standard-dose influenza vaccination in community-dwelling veterans.Clin Infect Dis. 2015 Jul 15;61(2):171-6. doi: 10.1093/cid/civ261. Epub 2015 Mar 31. Clin Infect Dis. 2015. PMID: 25829001
-
High-dose influenza vaccination and mortality among predominantly male, white, senior veterans, United States, 2012/13 to 2014/15.Euro Surveill. 2020 May;25(19):1900401. doi: 10.2807/1560-7917.ES.2020.25.19.1900401. Euro Surveill. 2020. PMID: 32431290 Free PMC article.
-
Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis.Expert Rev Vaccines. 2018 May;17(5):435-443. doi: 10.1080/14760584.2018.1471989. Epub 2018 May 16. Expert Rev Vaccines. 2018. PMID: 29715054 Review.
-
Effects of influenza immunization on pneumonia in the elderly.Hum Vaccin Immunother. 2018 Mar 4;14(3):744-749. doi: 10.1080/21645515.2017.1405200. Epub 2017 Dec 19. Hum Vaccin Immunother. 2018. PMID: 29135343 Free PMC article. Review.
Cited by
-
An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19).Cell Mol Biol Lett. 2022 May 13;27(1):38. doi: 10.1186/s11658-022-00339-3. Cell Mol Biol Lett. 2022. PMID: 35562685 Free PMC article. Review.
-
Predictors of influenza severity among hospitalized adults with laboratory confirmed influenza: Analysis of nine influenza seasons from the Valencia region, Spain.Influenza Other Respir Viruses. 2022 Sep;16(5):862-872. doi: 10.1111/irv.12985. Epub 2022 Apr 12. Influenza Other Respir Viruses. 2022. PMID: 35411561 Free PMC article.
-
Estimation of Relative Vaccine Effectiveness in Influenza: A Systematic Review of Methodology.Epidemiology. 2022 May 1;33(3):334-345. doi: 10.1097/EDE.0000000000001473. Epidemiology. 2022. PMID: 35213508 Free PMC article.
-
Influenza Vaccine Effectiveness Estimates among US Department of Defense Adult Beneficiaries over Four Consecutive Influenza Seasons: A Test-Negative Design Study with Different Control Groups.Vaccines (Basel). 2021 Dec 31;10(1):58. doi: 10.3390/vaccines10010058. Vaccines (Basel). 2021. PMID: 35062721 Free PMC article.
-
Economic Assessment of High-Dose Versus Adjuvanted Influenza Vaccine: An Evaluation of Hospitalization Costs Based on a Cohort Study.Vaccines (Basel). 2021 Sep 24;9(10):1065. doi: 10.3390/vaccines9101065. Vaccines (Basel). 2021. PMID: 34696173 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
